

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.69441149 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.69441149 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 6.35243247 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.69288305 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.69288305 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.69288305 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.69288305 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.69288305 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.69288305 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 5.40911970 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.39451648 |
| 12 | detection of other organism (GO:0098543) | 5.25697372 |
| 13 | detection of bacterium (GO:0016045) | 5.19099093 |
| 14 | leukocyte aggregation (GO:0070486) | 5.03142768 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.98526850 |
| 16 | DNA deamination (GO:0045006) | 4.76791631 |
| 17 | response to interleukin-15 (GO:0070672) | 4.75267586 |
| 18 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.65938790 |
| 19 | viral transcription (GO:0019083) | 4.63876918 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.62377188 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.60928995 |
| 22 | cellular response to interleukin-15 (GO:0071350) | 4.57405837 |
| 23 | translational termination (GO:0006415) | 4.47222225 |
| 24 | neutrophil activation (GO:0042119) | 4.44886452 |
| 25 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.44075659 |
| 26 | detection of external biotic stimulus (GO:0098581) | 4.42675709 |
| 27 | respiratory burst (GO:0045730) | 4.32752853 |
| 28 | negative regulation of interleukin-12 production (GO:0032695) | 4.14392651 |
| 29 | * cellular response to type I interferon (GO:0071357) | 4.10950349 |
| 30 | * type I interferon signaling pathway (GO:0060337) | 4.10950349 |
| 31 | * response to type I interferon (GO:0034340) | 4.07349875 |
| 32 | cellular extravasation (GO:0045123) | 4.06365456 |
| 33 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.06042296 |
| 34 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.03486796 |
| 35 | ribosomal small subunit biogenesis (GO:0042274) | 4.03147244 |
| 36 | response to host immune response (GO:0052572) | 4.02479899 |
| 37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.02479899 |
| 38 | detection of molecule of bacterial origin (GO:0032490) | 3.99854957 |
| 39 | translational elongation (GO:0006414) | 3.98035227 |
| 40 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.97528109 |
| 41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.95560521 |
| 42 | granulocyte activation (GO:0036230) | 3.95329251 |
| 43 | protein targeting to ER (GO:0045047) | 3.89557277 |
| 44 | cotranslational protein targeting to membrane (GO:0006613) | 3.89096229 |
| 45 | regulation of gamma-delta T cell activation (GO:0046643) | 3.88127790 |
| 46 | detection of biotic stimulus (GO:0009595) | 3.85181945 |
| 47 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.81579507 |
| 48 | maturation of SSU-rRNA (GO:0030490) | 3.78083526 |
| 49 | microglial cell activation (GO:0001774) | 3.72066701 |
| 50 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.70095045 |
| 51 | myeloid cell activation involved in immune response (GO:0002275) | 3.69365428 |
| 52 | regulation of mast cell degranulation (GO:0043304) | 3.68776268 |
| 53 | protein localization to endoplasmic reticulum (GO:0070972) | 3.68553756 |
| 54 | response to host (GO:0075136) | 3.68371951 |
| 55 | response to host defenses (GO:0052200) | 3.68371951 |
| 56 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.68371951 |
| 57 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.68124124 |
| 58 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.64941191 |
| 59 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.64395871 |
| 60 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.54723825 |
| 61 | regulation of T cell tolerance induction (GO:0002664) | 3.54186365 |
| 62 | negative regulation of T cell mediated immunity (GO:0002710) | 3.50270777 |
| 63 | viral life cycle (GO:0019058) | 3.49269613 |
| 64 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.48551033 |
| 65 | neutrophil mediated immunity (GO:0002446) | 3.48264070 |
| 66 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.47264109 |
| 67 | leukocyte degranulation (GO:0043299) | 3.44256579 |
| 68 | DNA strand elongation (GO:0022616) | 3.41743655 |
| 69 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.39944167 |
| 70 | translational initiation (GO:0006413) | 3.39827596 |
| 71 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.38925920 |
| 72 | regulation of B cell differentiation (GO:0045577) | 3.37487325 |
| 73 | regulation of tolerance induction (GO:0002643) | 3.34585391 |
| 74 | macrophage activation (GO:0042116) | 3.34025832 |
| 75 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.31896446 |
| 76 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.31577222 |
| 77 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.31577222 |
| 78 | * response to interferon-beta (GO:0035456) | 3.30595045 |
| 79 | regulation of mast cell activation (GO:0033003) | 3.26665704 |
| 80 | formation of translation preinitiation complex (GO:0001731) | 3.26646434 |
| 81 | dendritic cell chemotaxis (GO:0002407) | 3.25872593 |
| 82 | defense response to protozoan (GO:0042832) | 3.24982750 |
| 83 | negative regulation of innate immune response (GO:0045824) | 3.24604603 |
| 84 | cellular protein complex disassembly (GO:0043624) | 3.24568659 |
| 85 | positive regulation of mast cell activation (GO:0033005) | 3.24029619 |
| 86 | telomere maintenance via recombination (GO:0000722) | 3.23376505 |
| 87 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.22190661 |
| 88 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.21820581 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.21820581 |
| 90 | B cell receptor signaling pathway (GO:0050853) | 3.20613990 |
| 91 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.17171759 |
| 92 | tolerance induction (GO:0002507) | 3.16506492 |
| 93 | dendritic cell migration (GO:0036336) | 3.15907754 |
| 94 | negative thymic T cell selection (GO:0045060) | 3.12243033 |
| 95 | negative T cell selection (GO:0043383) | 3.09317389 |
| 96 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.07500029 |
| 97 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.07089772 |
| 98 | definitive hemopoiesis (GO:0060216) | 3.06638649 |
| 99 | regulation of regulatory T cell differentiation (GO:0045589) | 3.06577541 |
| 100 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.05221582 |
| 101 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.04714211 |
| 102 | myeloid leukocyte mediated immunity (GO:0002444) | 3.03892345 |
| 103 | regulation of leukocyte degranulation (GO:0043300) | 3.03080713 |
| 104 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.98768796 |
| 105 | negative regulation of interleukin-6 production (GO:0032715) | 2.97480718 |
| 106 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.97443138 |
| 107 | germinal center formation (GO:0002467) | 2.97173036 |
| 108 | positive thymic T cell selection (GO:0045059) | 2.96290616 |
| 109 | platelet dense granule organization (GO:0060155) | 2.93888004 |
| 110 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.93769029 |
| 111 | mast cell activation (GO:0045576) | 2.91924905 |
| 112 | protein complex disassembly (GO:0043241) | 2.88069723 |
| 113 | DNA replication initiation (GO:0006270) | 2.86628411 |
| 114 | mitotic recombination (GO:0006312) | 2.84473117 |
| 115 | ribosomal large subunit biogenesis (GO:0042273) | 2.80619081 |
| 116 | * response to interferon-alpha (GO:0035455) | 2.80210440 |
| 117 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.77042602 |
| 118 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.76901135 |
| 119 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.73271375 |
| 120 | IMP biosynthetic process (GO:0006188) | 2.72825275 |
| 121 | telomere maintenance via telomere lengthening (GO:0010833) | 2.72346376 |
| 122 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.67883108 |
| 123 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.67883108 |
| 124 | macromolecular complex disassembly (GO:0032984) | 2.66069083 |
| 125 | nucleobase biosynthetic process (GO:0046112) | 2.64731334 |
| 126 | translation (GO:0006412) | 2.63679081 |
| 127 | mRNA catabolic process (GO:0006402) | 2.61539457 |
| 128 | IMP metabolic process (GO:0046040) | 2.56216671 |
| 129 | DNA unwinding involved in DNA replication (GO:0006268) | 2.55887783 |
| 130 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.53086712 |
| 131 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.53005415 |
| 132 | protein targeting to membrane (GO:0006612) | 2.51143854 |
| 133 | RNA catabolic process (GO:0006401) | 2.50974617 |
| 134 | B cell mediated immunity (GO:0019724) | 2.50959500 |
| 135 | immunoglobulin mediated immune response (GO:0016064) | 2.50603486 |
| 136 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.46885636 |
| 137 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.44340777 |
| 138 | negative regulation of phagocytosis (GO:0050765) | 2.43959386 |
| 139 | purine nucleobase biosynthetic process (GO:0009113) | 2.41412078 |
| 140 | pseudouridine synthesis (GO:0001522) | 2.41402472 |
| 141 | proteasome assembly (GO:0043248) | 2.41296810 |
| 142 | T cell apoptotic process (GO:0070231) | 2.40619847 |
| 143 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.33205733 |
| 144 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.31783229 |
| 145 | ribosome biogenesis (GO:0042254) | 2.31252342 |
| 146 | rRNA processing (GO:0006364) | 2.29875534 |
| 147 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.29387989 |
| 148 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.28061144 |
| 149 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.25973403 |
| 150 | endosome to melanosome transport (GO:0035646) | 2.24169459 |
| 151 | endosome to pigment granule transport (GO:0043485) | 2.24169459 |
| 152 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.21674112 |
| 153 | CENP-A containing nucleosome assembly (GO:0034080) | 2.21673554 |
| 154 | purine-containing compound salvage (GO:0043101) | 2.21328505 |
| 155 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.19236789 |
| 156 | rRNA metabolic process (GO:0016072) | 2.18417136 |
| 157 | regulation of protein heterodimerization activity (GO:0043497) | 2.16898408 |
| 158 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.14679966 |
| 159 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.13890252 |
| 160 | telomere maintenance (GO:0000723) | 2.12800584 |
| 161 | chromatin remodeling at centromere (GO:0031055) | 2.12133113 |
| 162 | telomere organization (GO:0032200) | 2.11830751 |
| 163 | response to peptidoglycan (GO:0032494) | 2.09481055 |
| 164 | positive regulation of B cell differentiation (GO:0045579) | 2.09433924 |
| 165 | nucleoside salvage (GO:0043174) | 2.09139112 |
| 166 | DNA replication checkpoint (GO:0000076) | 2.06482742 |
| 167 | lymphocyte apoptotic process (GO:0070227) | 2.05456997 |
| 168 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.04705560 |
| 169 | mitotic nuclear envelope disassembly (GO:0007077) | 2.02970377 |
| 170 | cellular component biogenesis (GO:0044085) | 2.02165463 |
| 171 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.00739532 |
| 172 | establishment of integrated proviral latency (GO:0075713) | 2.00500624 |
| 173 | pinocytosis (GO:0006907) | 1.98868927 |
| 174 | viral mRNA export from host cell nucleus (GO:0046784) | 1.98516937 |
| 175 | response to protozoan (GO:0001562) | 1.97817119 |
| 176 | daunorubicin metabolic process (GO:0044597) | 1.97406399 |
| 177 | polyketide metabolic process (GO:0030638) | 1.97406399 |
| 178 | doxorubicin metabolic process (GO:0044598) | 1.97406399 |
| 179 | protein localization to kinetochore (GO:0034501) | 1.97070054 |
| 180 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 1.95572336 |
| 181 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 1.93364739 |
| 182 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 1.93362999 |
| 183 | cellular response to interferon-beta (GO:0035458) | 1.93186248 |
| 184 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 1.90869904 |
| 185 | kinetochore organization (GO:0051383) | 1.90468840 |
| 186 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 1.90114221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.91070285 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.67350383 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.52585860 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.47236404 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.08145568 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.64289532 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.60080684 |
| 8 | SPI1_23127762_ChIP-Seq_K562_Human | 2.48185117 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.43069880 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.37502429 |
| 11 | UTX_26944678_Chip-Seq_JUKART_Human | 2.32943259 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.28248730 |
| 13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.25937039 |
| 14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.25087635 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22536258 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.21155660 |
| 17 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.19489546 |
| 18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.16713278 |
| 19 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.13487790 |
| 20 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.12255861 |
| 21 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08076334 |
| 22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.05861578 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.00175016 |
| 24 | MAF_26560356_Chip-Seq_TH2_Human | 1.95271330 |
| 25 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.94833727 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.93442133 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.89098190 |
| 28 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.88607645 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.87584850 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84561557 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83821792 |
| 32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.83004042 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.82855537 |
| 34 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.80759781 |
| 35 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.79832694 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.78297720 |
| 37 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.78252821 |
| 38 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.77593026 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.77552629 |
| 40 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.77546656 |
| 41 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.75518685 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.75082967 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.74930723 |
| 44 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.72595459 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69750365 |
| 46 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.69648023 |
| 47 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.66936341 |
| 48 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.62772371 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59831640 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.59264957 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.58670990 |
| 52 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.58611235 |
| 53 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.57796171 |
| 54 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.57654226 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.57602592 |
| 56 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.56823284 |
| 57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56818374 |
| 58 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.56640842 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54857378 |
| 60 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.53246234 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52618231 |
| 62 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51149464 |
| 63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50123051 |
| 64 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.48752364 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48560266 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.47250327 |
| 67 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.47250178 |
| 68 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.46356478 |
| 69 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.46079060 |
| 70 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.45897553 |
| 71 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.45523487 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44490393 |
| 73 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.43192372 |
| 74 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.41606841 |
| 75 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41272393 |
| 76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40862999 |
| 77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37084956 |
| 78 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.36903429 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36207946 |
| 80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35625154 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33903858 |
| 82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33064562 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.32752208 |
| 84 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.32190041 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31437158 |
| 86 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.31004363 |
| 87 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.30379562 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29345423 |
| 89 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.27975754 |
| 90 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.27599770 |
| 91 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.27184606 |
| 92 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.26243480 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25743974 |
| 94 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.25038430 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.24628284 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23560143 |
| 97 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22926029 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.22679692 |
| 99 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.22666888 |
| 100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22394487 |
| 101 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.21721071 |
| 102 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.20773138 |
| 103 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.19295864 |
| 104 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.18914122 |
| 105 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18141277 |
| 106 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.17937062 |
| 107 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.17775827 |
| 108 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17347151 |
| 109 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.17245706 |
| 110 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17141296 |
| 111 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16762675 |
| 112 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.16698020 |
| 113 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16613971 |
| 114 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15478084 |
| 115 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15346314 |
| 116 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.15086122 |
| 117 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12962214 |
| 118 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.12650666 |
| 119 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12430357 |
| 120 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11863839 |
| 121 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.11516840 |
| 122 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.10405750 |
| 123 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.09382698 |
| 124 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07990021 |
| 125 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07496267 |
| 126 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07308490 |
| 127 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.06709147 |
| 128 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06538703 |
| 129 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06465698 |
| 130 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05215056 |
| 131 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.03889069 |
| 132 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03425577 |
| 133 | * MAF_26560356_Chip-Seq_TH1_Human | 1.01780870 |
| 134 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00314566 |
| 135 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99400367 |
| 136 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98652294 |
| 137 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.97699216 |
| 138 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97378266 |
| 139 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97311145 |
| 140 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.97106826 |
| 141 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96599669 |
| 142 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.95600343 |
| 143 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95353258 |
| 144 | MYB_26560356_Chip-Seq_TH2_Human | 0.95176225 |
| 145 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94948373 |
| 146 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.94811695 |
| 147 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94790249 |
| 148 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94598487 |
| 149 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.94425741 |
| 150 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93937012 |
| 151 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93635134 |
| 152 | MYB_26560356_Chip-Seq_TH1_Human | 0.93227147 |
| 153 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92213179 |
| 154 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90738400 |
| 155 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90719269 |
| 156 | P300_27268052_Chip-Seq_Bcells_Human | 0.90421653 |
| 157 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.90119318 |
| 158 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89335993 |
| 159 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88715959 |
| 160 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87960446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.23697985 |
| 2 | MP0006082_CNS_inflammation | 2.74222726 |
| 3 | MP0002396_abnormal_hematopoietic_system | 2.67744256 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.24707503 |
| 5 | MP0001545_abnormal_hematopoietic_system | 2.24386419 |
| 6 | MP0005397_hematopoietic_system_phenotyp | 2.24386419 |
| 7 | MP0003724_increased_susceptibility_to | 2.20544684 |
| 8 | MP0003693_abnormal_embryo_hatching | 2.12318905 |
| 9 | MP0003436_decreased_susceptibility_to | 2.11995495 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.05822361 |
| 11 | MP0006054_spinal_hemorrhage | 2.01456817 |
| 12 | MP0009785_altered_susceptibility_to | 1.99657347 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 1.96387082 |
| 14 | MP0003186_abnormal_redox_activity | 1.95745235 |
| 15 | MP0002277_abnormal_respiratory_mucosa | 1.94203396 |
| 16 | MP0004808_abnormal_hematopoietic_stem | 1.89596464 |
| 17 | MP0008007_abnormal_cellular_replicative | 1.86549734 |
| 18 | MP0003866_abnormal_defecation | 1.78826599 |
| 19 | MP0001853_heart_inflammation | 1.77218896 |
| 20 | MP0000685_abnormal_immune_system | 1.73635556 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.71727307 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 1.68177857 |
| 23 | MP0000490_abnormal_crypts_of | 1.67792903 |
| 24 | MP0004957_abnormal_blastocyst_morpholog | 1.67096361 |
| 25 | MP0010368_abnormal_lymphatic_system | 1.61460804 |
| 26 | MP0010094_abnormal_chromosome_stability | 1.60949060 |
| 27 | MP0005025_abnormal_response_to | 1.60820492 |
| 28 | MP0003077_abnormal_cell_cycle | 1.60685443 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.59556142 |
| 30 | MP0009278_abnormal_bone_marrow | 1.57870389 |
| 31 | MP0008057_abnormal_DNA_replication | 1.57214596 |
| 32 | MP0000343_altered_response_to | 1.55086352 |
| 33 | MP0008260_abnormal_autophagy | 1.50013857 |
| 34 | MP0002419_abnormal_innate_immunity | 1.47392861 |
| 35 | MP0005023_abnormal_wound_healing | 1.44736648 |
| 36 | MP0009379_abnormal_foot_pigmentation | 1.44713701 |
| 37 | MP0003279_aneurysm | 1.41640827 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.38505836 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.37910484 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.37383959 |
| 41 | MP0003111_abnormal_nucleus_morphology | 1.37222419 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.36480114 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.31101083 |
| 44 | MP0000858_altered_metastatic_potential | 1.29423582 |
| 45 | MP0001851_eye_inflammation | 1.27958872 |
| 46 | MP0005503_abnormal_tendon_morphology | 1.27423896 |
| 47 | MP0003705_abnormal_hypodermis_morpholog | 1.26858951 |
| 48 | MP0004510_myositis | 1.25472777 |
| 49 | MP0004883_abnormal_blood_vessel | 1.25161035 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.24485327 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.24011941 |
| 52 | MP0008058_abnormal_DNA_repair | 1.24003477 |
| 53 | MP0004381_abnormal_hair_follicle | 1.23537799 |
| 54 | MP0003075_altered_response_to | 1.23394242 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.21745813 |
| 56 | MP0002405_respiratory_system_inflammati | 1.21041516 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.20961932 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.20596383 |
| 59 | MP0001800_abnormal_humoral_immune | 1.20490843 |
| 60 | MP0002398_abnormal_bone_marrow | 1.19288488 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.18313116 |
| 62 | MP0009840_abnormal_foam_cell | 1.17105560 |
| 63 | MP0005671_abnormal_response_to | 1.16869609 |
| 64 | MP0005275_abnormal_skin_tensile | 1.15858454 |
| 65 | MP0002722_abnormal_immune_system | 1.14011620 |
| 66 | MP0002132_abnormal_respiratory_system | 1.13935880 |
| 67 | MP0002723_abnormal_immune_serum | 1.12112643 |
| 68 | MP0008469_abnormal_protein_level | 1.10829961 |
| 69 | MP0002420_abnormal_adaptive_immunity | 1.10638127 |
| 70 | MP0002877_abnormal_melanocyte_morpholog | 1.10050831 |
| 71 | MP0001819_abnormal_immune_cell | 1.09947227 |
| 72 | MP0003828_pulmonary_edema | 1.09237774 |
| 73 | MP0002006_tumorigenesis | 1.09178429 |
| 74 | MP0005164_abnormal_response_to | 1.07299276 |
| 75 | MP0001845_abnormal_inflammatory_respons | 1.07258365 |
| 76 | MP0002429_abnormal_blood_cell | 1.07053052 |
| 77 | MP0002998_abnormal_bone_remodeling | 1.06683740 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 1.05620351 |
| 79 | MP0005310_abnormal_salivary_gland | 1.04890207 |
| 80 | MP0002019_abnormal_tumor_incidence | 1.04173347 |
| 81 | MP0005166_decreased_susceptibility_to | 1.03055283 |
| 82 | MP0000716_abnormal_immune_system | 1.03007549 |
| 83 | MP0005174_abnormal_tail_pigmentation | 1.01292904 |
| 84 | MP0010307_abnormal_tumor_latency | 1.00898374 |
| 85 | MP0003567_abnormal_fetal_cardiomyocyte | 0.98195936 |
| 86 | MP0003172_abnormal_lysosome_physiology | 0.97907417 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 0.95878107 |
| 88 | MP0003763_abnormal_thymus_physiology | 0.95586789 |
| 89 | MP0001790_abnormal_immune_system | 0.94504682 |
| 90 | MP0005387_immune_system_phenotype | 0.94504682 |
| 91 | MP0001879_abnormal_lymphatic_vessel | 0.93216718 |
| 92 | MP0002933_joint_inflammation | 0.92838929 |
| 93 | MP0005451_abnormal_body_composition | 0.92806784 |
| 94 | MP0001663_abnormal_digestive_system | 0.92768359 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 0.92584750 |
| 96 | MP0005365_abnormal_bile_salt | 0.92218222 |
| 97 | MP0003448_altered_tumor_morphology | 0.91749220 |
| 98 | MP0000598_abnormal_liver_morphology | 0.90356418 |
| 99 | MP0005390_skeleton_phenotype | 0.89739778 |
| 100 | MP0009764_decreased_sensitivity_to | 0.86803548 |
| 101 | MP0000350_abnormal_cell_proliferation | 0.85333363 |
| 102 | MP0008004_abnormal_stomach_pH | 0.85015571 |
| 103 | MP0009763_increased_sensitivity_to | 0.83908648 |
| 104 | MP0000313_abnormal_cell_death | 0.83533732 |
| 105 | MP0003943_abnormal_hepatobiliary_system | 0.83020206 |
| 106 | MP0001873_stomach_inflammation | 0.82778309 |
| 107 | MP0003878_abnormal_ear_physiology | 0.82775005 |
| 108 | MP0005377_hearing/vestibular/ear_phenot | 0.82775005 |
| 109 | MP0003786_premature_aging | 0.81242289 |
| 110 | MP0001986_abnormal_taste_sensitivity | 0.80996775 |
| 111 | MP0005084_abnormal_gallbladder_morpholo | 0.79501696 |
| 112 | MP0005360_urolithiasis | 0.77480751 |
| 113 | MP0002060_abnormal_skin_morphology | 0.76950340 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.76490975 |
| 115 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75966439 |
| 116 | MP0001915_intracranial_hemorrhage | 0.75728481 |
| 117 | MP0003045_fibrosis | 0.75057804 |
| 118 | MP0005085_abnormal_gallbladder_physiolo | 0.74614546 |
| 119 | MP0000703_abnormal_thymus_morphology | 0.73147472 |
| 120 | MP0001764_abnormal_homeostasis | 0.73005679 |
| 121 | MP0000767_abnormal_smooth_muscle | 0.72939932 |
| 122 | MP0010030_abnormal_orbit_morphology | 0.72844786 |
| 123 | MP0004947_skin_inflammation | 0.71567200 |
| 124 | MP0009697_abnormal_copulation | 0.70358001 |
| 125 | MP0008932_abnormal_embryonic_tissue | 0.70215296 |
| 126 | MP0003011_delayed_dark_adaptation | 0.69512267 |
| 127 | MP0003300_gastrointestinal_ulcer | 0.69478167 |
| 128 | MP0000249_abnormal_blood_vessel | 0.68712013 |
| 129 | MP0003690_abnormal_glial_cell | 0.68092226 |
| 130 | MP0005083_abnormal_biliary_tract | 0.67784517 |
| 131 | MP0003795_abnormal_bone_structure | 0.67176586 |
| 132 | MP0004858_abnormal_nervous_system | 0.61000662 |
| 133 | MP0002653_abnormal_ependyma_morphology | 0.60650557 |
| 134 | MP0008874_decreased_physiological_sensi | 0.57395731 |
| 135 | MP0001542_abnormal_bone_strength | 0.56342727 |
| 136 | MP0002254_reproductive_system_inflammat | 0.53924984 |
| 137 | MP0001958_emphysema | 0.52328672 |
| 138 | MP0002928_abnormal_bile_duct | 0.52023309 |
| 139 | MP0008873_increased_physiological_sensi | 0.51733852 |
| 140 | MP0005381_digestive/alimentary_phenotyp | 0.49349808 |
| 141 | MP0003252_abnormal_bile_duct | 0.47249368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 5.48353200 |
| 2 | Optic neuritis (HP:0100653) | 5.45079956 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 5.45079956 |
| 4 | Hypochromic microcytic anemia (HP:0004840) | 4.92612708 |
| 5 | Obstructive lung disease (HP:0006536) | 4.58204844 |
| 6 | Chronic obstructive pulmonary disease (HP:0006510) | 4.58204844 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.50006417 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.30227119 |
| 9 | Meningitis (HP:0001287) | 4.30194458 |
| 10 | Gastrointestinal infarctions (HP:0005244) | 4.27499073 |
| 11 | Thrombocytosis (HP:0001894) | 4.24755779 |
| 12 | Reticulocytopenia (HP:0001896) | 4.15954320 |
| 13 | Encephalitis (HP:0002383) | 4.10290511 |
| 14 | Aplastic anemia (HP:0001915) | 4.07832885 |
| 15 | Hypochromic anemia (HP:0001931) | 4.06143974 |
| 16 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.02855809 |
| 17 | Abnormal number of erythroid precursors (HP:0012131) | 3.98765443 |
| 18 | Keratoconjunctivitis sicca (HP:0001097) | 3.90583469 |
| 19 | Increased IgE level (HP:0003212) | 3.87495283 |
| 20 | Recurrent skin infections (HP:0001581) | 3.87082135 |
| 21 | Keratoconjunctivitis (HP:0001096) | 3.72697931 |
| 22 | Urticaria (HP:0001025) | 3.68577122 |
| 23 | Vasculitis (HP:0002633) | 3.65657773 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.58132867 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.58132867 |
| 26 | Increased IgM level (HP:0003496) | 3.36746520 |
| 27 | Gingivitis (HP:0000230) | 3.36719650 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.31607915 |
| 29 | Chest pain (HP:0100749) | 3.28158371 |
| 30 | Petechiae (HP:0000967) | 3.23413874 |
| 31 | Episodic fever (HP:0001954) | 3.21622008 |
| 32 | Pulmonary infiltrates (HP:0002113) | 3.13872695 |
| 33 | Anorexia (HP:0002039) | 3.12328505 |
| 34 | Hemoptysis (HP:0002105) | 3.09352469 |
| 35 | Protrusio acetabuli (HP:0003179) | 3.09124811 |
| 36 | Abnormality of T cell number (HP:0011839) | 3.02688624 |
| 37 | Leukocytosis (HP:0001974) | 3.01981764 |
| 38 | Reduced antithrombin III activity (HP:0001976) | 2.99356818 |
| 39 | Panhypogammaglobulinemia (HP:0003139) | 2.97933454 |
| 40 | Abnormality of T cells (HP:0002843) | 2.97351074 |
| 41 | T lymphocytopenia (HP:0005403) | 2.97103859 |
| 42 | Myositis (HP:0100614) | 2.91748859 |
| 43 | Granulocytopenia (HP:0001913) | 2.83536718 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.76567410 |
| 45 | Pulmonary embolism (HP:0002204) | 2.74488528 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.72509500 |
| 47 | Hypergammaglobulinemia (HP:0010702) | 2.71098605 |
| 48 | Recurrent abscess formation (HP:0002722) | 2.70918941 |
| 49 | Arterial thrombosis (HP:0004420) | 2.69736117 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.69509156 |
| 51 | Type I transferrin isoform profile (HP:0003642) | 2.67743104 |
| 52 | Oral leukoplakia (HP:0002745) | 2.64405121 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.61760522 |
| 54 | Vertebral compression fractures (HP:0002953) | 2.58288817 |
| 55 | Abnormality of the pleura (HP:0002103) | 2.57550920 |
| 56 | Pallor (HP:0000980) | 2.56419623 |
| 57 | Lymphopenia (HP:0001888) | 2.55548524 |
| 58 | Recurrent viral infections (HP:0004429) | 2.53808554 |
| 59 | Osteomyelitis (HP:0002754) | 2.45159022 |
| 60 | Eosinophilia (HP:0001880) | 2.43468325 |
| 61 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.43290186 |
| 62 | Recurrent bacterial skin infections (HP:0005406) | 2.43159862 |
| 63 | Sepsis (HP:0100806) | 2.41272262 |
| 64 | Gangrene (HP:0100758) | 2.41011675 |
| 65 | Biconcave vertebral bodies (HP:0004586) | 2.40889055 |
| 66 | Abnormality of the peritoneum (HP:0002585) | 2.36533533 |
| 67 | Epistaxis (HP:0000421) | 2.36514393 |
| 68 | IgM deficiency (HP:0002850) | 2.35696512 |
| 69 | Spontaneous hematomas (HP:0007420) | 2.34838361 |
| 70 | Macrocytic anemia (HP:0001972) | 2.33991887 |
| 71 | Hepatosplenomegaly (HP:0001433) | 2.33639258 |
| 72 | Amyloidosis (HP:0011034) | 2.32984234 |
| 73 | Abnormality of the pericardium (HP:0001697) | 2.30704829 |
| 74 | Selective tooth agenesis (HP:0001592) | 2.29902499 |
| 75 | Agammaglobulinemia (HP:0004432) | 2.28708722 |
| 76 | Premature loss of primary teeth (HP:0006323) | 2.24984276 |
| 77 | Purpura (HP:0000979) | 2.24319515 |
| 78 | 11 pairs of ribs (HP:0000878) | 2.22451422 |
| 79 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.21790947 |
| 80 | Colon cancer (HP:0003003) | 2.21223198 |
| 81 | Abnormal platelet function (HP:0011869) | 2.20929257 |
| 82 | Impaired platelet aggregation (HP:0003540) | 2.20929257 |
| 83 | Recurrent bronchitis (HP:0002837) | 2.20659365 |
| 84 | Skin ulcer (HP:0200042) | 2.19974032 |
| 85 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.19941249 |
| 86 | Nasal polyposis (HP:0100582) | 2.16197545 |
| 87 | Acne (HP:0001061) | 2.15630656 |
| 88 | Glomerulopathy (HP:0100820) | 2.15269588 |
| 89 | Poor head control (HP:0002421) | 2.14236201 |
| 90 | Orchitis (HP:0100796) | 2.12726942 |
| 91 | Toxemia of pregnancy (HP:0100603) | 2.12510853 |
| 92 | Acute hepatic failure (HP:0006554) | 2.11320890 |
| 93 | Keratitis (HP:0000491) | 2.10987256 |
| 94 | Gingival bleeding (HP:0000225) | 2.07987568 |
| 95 | Skin rash (HP:0000988) | 2.05838191 |
| 96 | Abnormality of eosinophils (HP:0001879) | 2.03809533 |
| 97 | Eczematoid dermatitis (HP:0000976) | 2.03649679 |
| 98 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.00868400 |
| 99 | Beaking of vertebral bodies (HP:0004568) | 2.00735870 |
| 100 | Autoimmune hemolytic anemia (HP:0001890) | 2.00303671 |
| 101 | Cervical subluxation (HP:0003308) | 1.99979835 |
| 102 | Abnormality of the endocardium (HP:0004306) | 1.99630047 |
| 103 | Vertigo (HP:0002321) | 1.98114495 |
| 104 | Vacuolated lymphocytes (HP:0001922) | 1.96746177 |
| 105 | Abnormality of T cell physiology (HP:0011840) | 1.96218430 |
| 106 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.96169440 |
| 107 | Peritonitis (HP:0002586) | 1.95933534 |
| 108 | Abnormality of complement system (HP:0005339) | 1.95621301 |
| 109 | Abnormal platelet volume (HP:0011876) | 1.94968091 |
| 110 | Hypertensive crisis (HP:0100735) | 1.94408641 |
| 111 | Myelodysplasia (HP:0002863) | 1.93729594 |
| 112 | Recurrent pneumonia (HP:0006532) | 1.91819792 |
| 113 | Periodontitis (HP:0000704) | 1.91077484 |
| 114 | IgG deficiency (HP:0004315) | 1.88725614 |
| 115 | Chronic otitis media (HP:0000389) | 1.88654361 |
| 116 | Abnormal protein glycosylation (HP:0012346) | 1.87901992 |
| 117 | Abnormal glycosylation (HP:0012345) | 1.87901992 |
| 118 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.87901992 |
| 119 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.87901992 |
| 120 | Nonimmune hydrops fetalis (HP:0001790) | 1.87893062 |
| 121 | Multiple enchondromatosis (HP:0005701) | 1.87374847 |
| 122 | Glomerulonephritis (HP:0000099) | 1.87089313 |
| 123 | Recurrent lower respiratory tract infections (HP:0002783) | 1.85749308 |
| 124 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.85478086 |
| 125 | Degeneration of anterior horn cells (HP:0002398) | 1.85379339 |
| 126 | Abnormality of the anterior horn cell (HP:0006802) | 1.85379339 |
| 127 | Syringomyelia (HP:0003396) | 1.84793393 |
| 128 | Spinal cord lesions (HP:0100561) | 1.84793393 |
| 129 | Joint swelling (HP:0001386) | 1.84510350 |
| 130 | Ankle contracture (HP:0006466) | 1.84314498 |
| 131 | Mediastinal lymphadenopathy (HP:0100721) | 1.83997075 |
| 132 | Polycythemia (HP:0001901) | 1.83391708 |
| 133 | Osteolytic defects of the hand bones (HP:0009699) | 1.82717075 |
| 134 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.82717075 |
| 135 | Microretrognathia (HP:0000308) | 1.82322222 |
| 136 | Nausea (HP:0002018) | 1.81528874 |
| 137 | Interstitial pulmonary disease (HP:0006530) | 1.80988120 |
| 138 | Complement deficiency (HP:0004431) | 1.80424027 |
| 139 | Abnormality of the prostate (HP:0008775) | 1.79501033 |
| 140 | Cellulitis (HP:0100658) | 1.79156273 |
| 141 | Autoimmune thrombocytopenia (HP:0001973) | 1.78859056 |
| 142 | Pancytopenia (HP:0001876) | 1.76950067 |
| 143 | Acute myeloid leukemia (HP:0004808) | 1.75993087 |
| 144 | Agnosia (HP:0010524) | 1.75171693 |
| 145 | Increased mean platelet volume (HP:0011877) | 1.74720538 |
| 146 | Birth length less than 3rd percentile (HP:0003561) | 1.73466168 |
| 147 | Increased serum ferritin (HP:0003281) | 1.73295949 |
| 148 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.71372198 |
| 149 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.71372198 |
| 150 | Amaurosis fugax (HP:0100576) | 1.70946101 |
| 151 | Generalized aminoaciduria (HP:0002909) | 1.70595561 |
| 152 | Abnormality of the intrinsic pathway (HP:0010989) | 1.70225433 |
| 153 | Sparse eyelashes (HP:0000653) | 1.69956654 |
| 154 | Joint hemorrhage (HP:0005261) | 1.69560156 |
| 155 | Microcytic anemia (HP:0001935) | 1.69171888 |
| 156 | Pustule (HP:0200039) | 1.68081362 |
| 157 | Rough bone trabeculation (HP:0100670) | 1.67853225 |
| 158 | Muscle fiber atrophy (HP:0100295) | 1.67441144 |
| 159 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.66875257 |
| 160 | Abnormality of the nasal mucosa (HP:0000433) | 1.66730754 |
| 161 | Abnormality of the common coagulation pathway (HP:0010990) | 1.65782940 |
| 162 | Abnormality of iron homeostasis (HP:0011031) | 1.63392425 |
| 163 | Trismus (HP:0000211) | 1.62524289 |
| 164 | Thrombophlebitis (HP:0004418) | 1.61501804 |
| 165 | Abnormality of macrophages (HP:0004311) | 1.61444553 |
| 166 | Abnormality of reticulocytes (HP:0004312) | 1.59594108 |
| 167 | Abnormal hemoglobin (HP:0011902) | 1.59295462 |
| 168 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.56615718 |
| 169 | Mesangial abnormality (HP:0001966) | 1.54425204 |
| 170 | Menorrhagia (HP:0000132) | 1.52530218 |
| 171 | Neoplasm of head and neck (HP:0012288) | 1.51837828 |
| 172 | Esophageal neoplasm (HP:0100751) | 1.51837828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.61216924 |
| 2 | TNK2 | 2.86814564 |
| 3 | NME2 | 2.86566899 |
| 4 | PIM2 | 2.85272064 |
| 5 | CSK | 2.75790240 |
| 6 | GRK6 | 2.74174015 |
| 7 | FES | 2.73218992 |
| 8 | WEE1 | 2.60946557 |
| 9 | ERN1 | 2.53464287 |
| 10 | EPHB1 | 2.36320450 |
| 11 | FLT3 | 2.26929542 |
| 12 | TGFBR1 | 2.26391633 |
| 13 | KIT | 2.08106851 |
| 14 | KDR | 2.01243034 |
| 15 | HCK | 1.87298995 |
| 16 | MAP2K3 | 1.87229588 |
| 17 | BUB1 | 1.78434388 |
| 18 | RPS6KB2 | 1.75254161 |
| 19 | TGFBR2 | 1.71010279 |
| 20 | BCKDK | 1.68834945 |
| 21 | BTK | 1.68625535 |
| 22 | TAOK1 | 1.67340325 |
| 23 | RPS6KA4 | 1.65274319 |
| 24 | PAK4 | 1.64669610 |
| 25 | TEC | 1.59077788 |
| 26 | STK16 | 1.56771934 |
| 27 | TYK2 | 1.52175224 |
| 28 | CDK7 | 1.51632828 |
| 29 | TBK1 | 1.50803536 |
| 30 | TIE1 | 1.48045599 |
| 31 | VRK1 | 1.47918399 |
| 32 | EIF2AK1 | 1.46931051 |
| 33 | BLK | 1.46455374 |
| 34 | ACVR1B | 1.45514846 |
| 35 | LRRK2 | 1.43665688 |
| 36 | FGR | 1.42350009 |
| 37 | MAP4K1 | 1.41490100 |
| 38 | PIM1 | 1.35837914 |
| 39 | MAPKAPK3 | 1.34962793 |
| 40 | CDC7 | 1.33944284 |
| 41 | LCK | 1.32583550 |
| 42 | IRAK4 | 1.32179943 |
| 43 | SIK3 | 1.31556333 |
| 44 | JAK2 | 1.31324037 |
| 45 | JAK1 | 1.30844282 |
| 46 | MAP3K13 | 1.30784508 |
| 47 | JAK3 | 1.30775890 |
| 48 | EEF2K | 1.30277730 |
| 49 | BRSK2 | 1.29442843 |
| 50 | IKBKB | 1.29114098 |
| 51 | MATK | 1.25809620 |
| 52 | ITK | 1.25809589 |
| 53 | SCYL2 | 1.25194510 |
| 54 | PKN2 | 1.23354426 |
| 55 | EIF2AK3 | 1.20523182 |
| 56 | MAP3K14 | 1.18318029 |
| 57 | MYLK | 1.17304202 |
| 58 | DYRK3 | 1.16100147 |
| 59 | IRAK3 | 1.16008751 |
| 60 | MAP3K11 | 1.15443174 |
| 61 | ZAP70 | 1.14940445 |
| 62 | MAP3K1 | 1.13735122 |
| 63 | PRPF4B | 1.12360625 |
| 64 | CDK19 | 1.11667358 |
| 65 | PRKD2 | 1.09118257 |
| 66 | TESK2 | 1.06253243 |
| 67 | CDK8 | 1.04548879 |
| 68 | MAP3K3 | 1.02626677 |
| 69 | MKNK1 | 1.02493071 |
| 70 | NEK2 | 1.02362618 |
| 71 | MARK3 | 0.99961457 |
| 72 | ATR | 0.98547876 |
| 73 | CSF1R | 0.98415728 |
| 74 | IKBKE | 0.97416583 |
| 75 | PTK6 | 0.96678423 |
| 76 | PASK | 0.96559213 |
| 77 | STK10 | 0.94240904 |
| 78 | SRPK1 | 0.92466060 |
| 79 | ZAK | 0.92418566 |
| 80 | CDK6 | 0.89737552 |
| 81 | CDK4 | 0.87976287 |
| 82 | AURKB | 0.86007811 |
| 83 | ABL2 | 0.83115100 |
| 84 | TESK1 | 0.82401903 |
| 85 | PIK3CG | 0.81974572 |
| 86 | KSR2 | 0.80072053 |
| 87 | CHUK | 0.79912573 |
| 88 | PRKG2 | 0.77315586 |
| 89 | NEK9 | 0.76972834 |
| 90 | PTK2B | 0.75799743 |
| 91 | IRAK1 | 0.75221787 |
| 92 | EIF2AK2 | 0.74953991 |
| 93 | MAP3K8 | 0.74695950 |
| 94 | STK4 | 0.73953639 |
| 95 | PDK1 | 0.73271425 |
| 96 | BMPR2 | 0.71729480 |
| 97 | SIK2 | 0.71561541 |
| 98 | MARK2 | 0.71521047 |
| 99 | ILK | 0.71519722 |
| 100 | PRKCQ | 0.71008291 |
| 101 | TAOK2 | 0.70505400 |
| 102 | SMG1 | 0.70467030 |
| 103 | PLK4 | 0.70380461 |
| 104 | FYN | 0.69541646 |
| 105 | PLK1 | 0.68773879 |
| 106 | NEK1 | 0.67996359 |
| 107 | EPHA3 | 0.66096535 |
| 108 | LYN | 0.65326206 |
| 109 | MAP3K7 | 0.63261019 |
| 110 | PDPK1 | 0.59717080 |
| 111 | TRPM7 | 0.59395633 |
| 112 | RPS6KA6 | 0.57808760 |
| 113 | MAP3K6 | 0.57552240 |
| 114 | TSSK6 | 0.56839566 |
| 115 | MAP2K6 | 0.53461604 |
| 116 | TRIB3 | 0.52445386 |
| 117 | CSNK2A1 | 0.52193890 |
| 118 | NLK | 0.51149368 |
| 119 | MAPKAPK2 | 0.51002353 |
| 120 | TAOK3 | 0.50794333 |
| 121 | GRK7 | 0.49784549 |
| 122 | RPS6KC1 | 0.49607939 |
| 123 | RPS6KL1 | 0.49607939 |
| 124 | PAK2 | 0.49117116 |
| 125 | MAP3K5 | 0.48701093 |
| 126 | STK38 | 0.47482165 |
| 127 | SYK | 0.46712118 |
| 128 | MAPK12 | 0.46509886 |
| 129 | TLK1 | 0.45368188 |
| 130 | FGFR4 | 0.45108903 |
| 131 | HIPK2 | 0.45058967 |
| 132 | TXK | 0.44991741 |
| 133 | MAP3K12 | 0.44364347 |
| 134 | MAP3K10 | 0.44082761 |
| 135 | EPHA2 | 0.43855441 |
| 136 | YES1 | 0.43128968 |
| 137 | DYRK1B | 0.42496404 |
| 138 | STK11 | 0.41806552 |
| 139 | MAPK11 | 0.41801828 |
| 140 | PRKCD | 0.41214653 |
| 141 | MAPK7 | 0.40719413 |
| 142 | MAPK4 | 0.40697884 |
| 143 | IRAK2 | 0.40274837 |
| 144 | PAK1 | 0.40030768 |
| 145 | ADRBK1 | 0.39807066 |
| 146 | MAP2K4 | 0.39291891 |
| 147 | CDC42BPA | 0.38886839 |
| 148 | SIK1 | 0.38273149 |
| 149 | ALK | 0.34236370 |
| 150 | DAPK2 | 0.32802231 |
| 151 | RAF1 | 0.29747492 |
| 152 | PRKD1 | 0.28962748 |
| 153 | ABL1 | 0.26612492 |
| 154 | PRKCH | 0.26520161 |
| 155 | PRKCZ | 0.25764674 |
| 156 | BMX | 0.24602966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.95725854 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.93023612 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.30139043 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.99879115 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.99022401 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.96200178 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.86269195 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.32313795 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.31123142 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.17921703 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.12116841 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.09554900 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.08398740 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.07650564 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.99408399 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.92297193 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.89732677 |
| 18 | Spliceosome_Homo sapiens_hsa03040 | 1.87665201 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.84183105 |
| 20 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.78110777 |
| 21 | RNA polymerase_Homo sapiens_hsa03020 | 1.76094452 |
| 22 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.74842994 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.68948455 |
| 24 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.62137696 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.59237596 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.56844187 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53749995 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.49249967 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.46043873 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.45895561 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42790507 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41081607 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.36524940 |
| 34 | RNA transport_Homo sapiens_hsa03013 | 1.35505738 |
| 35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.32111364 |
| 36 | Cell cycle_Homo sapiens_hsa04110 | 1.31369749 |
| 37 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.25842636 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21061574 |
| 39 | RNA degradation_Homo sapiens_hsa03018 | 1.18029038 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.17252184 |
| 41 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.16667148 |
| 42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.16048198 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15879423 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.11283870 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 1.09234386 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.07811415 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.07383121 |
| 48 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.07308049 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05899456 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05454782 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03444488 |
| 52 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.03059868 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 1.02771558 |
| 54 | Protein export_Homo sapiens_hsa03060 | 1.02267745 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01877704 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.00799378 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00738864 |
| 58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.00526026 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.99918484 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.98784363 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.98413936 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97556758 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.97040662 |
| 64 | Salmonella infection_Homo sapiens_hsa05132 | 0.93957948 |
| 65 | Measles_Homo sapiens_hsa05162 | 0.93916106 |
| 66 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.90817402 |
| 67 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.90409245 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90046406 |
| 69 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.88873473 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87049165 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.85206207 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83990362 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82155373 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.80347262 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.79175163 |
| 76 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79138728 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78389010 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.76560221 |
| 79 | Purine metabolism_Homo sapiens_hsa00230 | 0.75521394 |
| 80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75270873 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.75077005 |
| 82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.74867521 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74770554 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.74297909 |
| 85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.72209199 |
| 86 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71851256 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70072147 |
| 88 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.69638794 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69021897 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68187006 |
| 91 | Influenza A_Homo sapiens_hsa05164 | 0.68086928 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.68007579 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67815660 |
| 94 | Asthma_Homo sapiens_hsa05310 | 0.67536778 |
| 95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65698878 |
| 96 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64237210 |
| 97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63309872 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63217651 |
| 99 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62755545 |
| 100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.60310171 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59423981 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.59193404 |
| 103 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59149507 |
| 104 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.59061264 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58615002 |
| 106 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58339086 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58160644 |
| 108 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57790963 |
| 109 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.57236976 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.57125804 |
| 111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55945446 |
| 112 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54311868 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53207013 |
| 114 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52785089 |
| 115 | Basal transcription factors_Homo sapiens_hsa03022 | 0.52659170 |
| 116 | Peroxisome_Homo sapiens_hsa04146 | 0.51349191 |
| 117 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50880543 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50352540 |
| 119 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49608524 |
| 120 | Retinol metabolism_Homo sapiens_hsa00830 | 0.48784148 |
| 121 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.48732423 |
| 122 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48478038 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46991865 |
| 124 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45830610 |
| 125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45039584 |
| 126 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.44986748 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43247668 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.43246978 |
| 129 | Allograft rejection_Homo sapiens_hsa05330 | 0.42165298 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42106025 |
| 131 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42103320 |
| 132 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41337334 |
| 133 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40802705 |
| 134 | Lysosome_Homo sapiens_hsa04142 | 0.40790498 |
| 135 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39910748 |
| 136 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38411852 |
| 137 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36040054 |
| 138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34297303 |
| 139 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33836042 |
| 140 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33619814 |
| 141 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33464367 |
| 142 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.30470298 |
| 143 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.30091754 |
| 144 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30070899 |
| 145 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29972821 |
| 146 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28577794 |
| 147 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26504574 |
| 148 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26300737 |
| 149 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.25362070 |
| 150 | Insulin resistance_Homo sapiens_hsa04931 | 0.24914486 |
| 151 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.23342466 |
| 152 | Colorectal cancer_Homo sapiens_hsa05210 | 0.18538607 |
| 153 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17514609 |
| 154 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.14168335 |
| 155 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.13196708 |

